For patients undergoing surgical procedures, there is no association between liberal preprocedural fasting policies and ...

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

Quantitative CT textures may provide imaging evidence of the spatial heterogeneity of lung inflammation and disease burden in COPD.

How accurate are low-complexity manual nucleic acid amplification tests for detecting pulmonary tuberculosis in children? - There is limited evidence that LC-mNAATs can correctly identify pulmonary ...

Roivant Sciences Ltd. (NASDAQ: ROIV) is one of the best biotech stocks to invest in now. On June 16, Pulmovant, a Roivant ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced the receipt of an additional $50.0 ...

Increased eosinophil levels in COPD were associated with impaired abdominal aortic dynamics, highlighting a mechanistic link between eosinophilic inflammation and vascular dysfunction.

Multimorbidity is common in SSc and is linked to reduced survival and physical function, particularly among patients with cardiovascular and renal comorbidities.

Gunnarsson K, et al. Hematological malignancies in systemic sclerosis, a population-based nationwide register study. Presented at EULAR 2025; OP0221. DOI: 10.1136/annrheumdis-2025-eular.B444.

Pulmonary function tests (PFTs) play an important role in screening and following-up pulmonary involvement in systemic sclerosis (SSc). However, some patients are not able to perform PFTs due to ...

This systematic review and meta-analysis aim to explore the available evidence on the clinical data of pembrolizumab in treating primary pulmonary NUT carcinoma, focusing on progression-free survival ...